HEXO Corp

HEXO Corp. engages in the provision of cannabis and cannabis products. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hydropothecary is a licensed producer of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations.Their leadership team brings proven scientific, financial, regulatory and entrepreneurial expertise to the rapidly evolving Canadian medical marijuana industry.Hydropothecary is an award-winning medical cannabis producer located on a 143-acre farm in Gatineau, Quebec, in the National Capital Region. Their focus is on product innovation, advanced natural growing techniques, client health and safety, and exceptional customer service. They take their commitment to customers seriously, offering exceptional packaging, courier delivery in Canada (Saturdays where available) and their bilingual, 24-hour customer service.

Aurora Cannabis

CannTrust Holdings

SNDL Inc.

These popular pot stocks might be kicked off the New York Stock Exchange or Nasdaq this year.

4 Marijuana Stocks Could Soon Face Delisting

Great quarterly results for the biggest Canadian cannabis producer generated enthusiasm about HEXO's prospects.

Why HEXO Shares Soared 18.9% Today

Canopy Growth

MedMen Enterprises Inc.

Tilray Brands

The cannabis industry has a major cash problem.

10 Pot Stocks That Could Run Out of Money in 10 Months (or Less)

Aphria

Cronos Group

Scotts Miracle-Gro

After a brutal year in 2019, cannabis stocks are off to another rough start so far in 2020.

7 Cannabis Stocks To Buy, Sell And Hold

Two brand-name pot stock CEOs have resigned in less than two weeks, and this company's leader may be next.

This Is the Next Cannabis Stock CEO Who Needs to Go

The green rush has officially hit the growing pains stage.

4 Brand-Name Cannabis Stocks Laying Off Workers

Nathalie Bourque's exit is effective immediately.

HEXO Director Resigns

OTTAWA, Feb.  07, 2020  (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) wishes to announce two corporate developments. HEXO has changed its auditor from MNP LLP to PricewaterhouseCoopers LLP effective January 31, 2020. In addition, Nathalie Bourque is resigning from HEXO’s Board of Directors, effective today.

HEXO Corp provides corporate update

These two Canadian pot stocks might be worth adding to your portfolio this month.

2 Best Cannabis Stocks to Buy in February

Management changes could become the new norm in the cannabis space.

MedMen's CEO Resigned, and These Pot Stock CEOs Could Be Next

Pot stocks have been in the midst of a free fall for much of the past year. Could bankruptcy be a lifeline?

Could This Surprising Move Save The Cannabis Industry?

Bigger worries, including NYSE delisting, may await this embattled cannabis stock.

Wall Street Downgraded This Popular Pot Stock and Slashed Its Price Target by 70%

Hexo Corp.'s U.S.-listed shares HEXO, -5.67% HEXO, -4.89% slid 3% in premarket trade Tuesday, after MKM downgraded the Canadian cannabis company to neutral from buy after it was sued by Medipharm Labs Corp.

Hexo shares slide 3% premarket after MKM downgrades stock following breach of contract lawsuit

The dispute is over nearly CA$10 million in unpaid bills stemming from a 2019 supply deal.

Medipharm Labs Sues HEXO for Breach of Contract

Licensed cannabis producer Hexo Corp. HEXO, -5.67% HEXO, -4.89% is being sued by Medipharm Labs Inc.

Medipharm sues Hexo for $7.5 million in non-payment dispute

OrganiGram Holdings Inc.

With Canadian pot sales expected to hit $5 billion annually by 2024, it pays to know the biggest names in the industry.

The 10 Largest Canadian Marijuana Stocks

The grass isn't always greener in the budding cannabis industry.

3 Marijuana Stock Trends for 2020 That Are All Bad News

Investors are concerned that the company is resorting frequently to stock flotations to raise capital.

HEXO Closes $20M Share Issue That Tanked Stock

OTTAWA, Jan.  22, 2020  (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced it has closed its previously announced registered direct offering with institutional investors (the “Offering”). Under the Offering, the Company sold 11,976,048 common shares at an offering price of US$1.67 per share for gross proceeds of US$20.0 million before deducting fees and other estimated offering expenses. The Company also issued to the investors common share purchase warrants to purchase 5,988,024 common shares of the Company. The warrants will have a five year-term and an exercise price of US$2.45 per share. A.G.P./Alliance Global Partners acted as sole placement agent for the Offering.

HEXO Corp. Closes US$20.0 Million Registered Direct Offering

New data suggests that cannabis stock pessimism may finally be waning.

Finally, Some Good News for Marijuana Stocks

The cannabis industry could rebound this year, but HEXO shouldn’t be atop your buy list.

1 Cannabis Stock to Avoid At All Costs

First some HEXO shares go on sale -- then they all do.

Why HEXO Corp Stock Dropped 9% Today

The company is raising gross proceeds of $20 million with the move.

HEXO Floats $20 Million Share Issue, Sinking Stock

Hexo Corp. (NYSE: HEXO) shares slid on Friday after the Canadian cannabis firm announced that it is conducting a direct offering of $20 million worth of shares.

Will Hexo’s Direct Offering Help Push the Stock Higher?

Hexo Corp. hexp HEXO, -4.15% shares slid 6% in premarket trade Friday, after the Canadian cannabis company said it plans to sell shares to raise $20 million in funding.

News for HEXO Corp Stock (HEXO)